Cerebellar Involvement in Cognitive Sequencing
Investigation of Cerebellar Involvement in Cognitive Sequencing
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: John E Desmond, Ph.D.
- Phone Number: 410-502-3583
- Email: jdesmon2@jhmi.edu
Study Contact Backup
- Name: JoAnna Mathena, MS
- Phone Number: 443-571-0947
- Email: labnim@jh.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Recruiting
- Johns Hopkins University School of Medicine
-
Contact:
- John E. Desmond, Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 1) Age 18-50;
- 2) educational attainment of at least 8 years;
- 3) capable of giving informed consent;
- 4) fluent speaker of English by self-report;
- 5) right handed.
Exclusion Criteria:
- 1) illicit drug use within 30 days of MRI scanning;
- 2) neurological or systemic disorder which can cause dementia or cognitive dysfunction;
- 3) history of an Axis I psychiatric disorder including substance use disorder;
- 4) history of definite stroke;
- 5) focal lesion on MRI exam;
- 6) uncorrected visual deficits by self-report
- 7) contraindications for MRI scanning
- 8) use of anxiolytic, antidepressant, neuroleptic, or sedative medication
- 9) Additional exclusion criteria recommended by Wassermann for TMS neuromodulation, including: History of seizure or a family history of epilepsy, heart disease, intracardiac lines, increased intracranial pressure, history of head trauma, and history of respiratory disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Cerebellar Stimulation
TMS will be administered to the cerebellum on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task.
Task order will be counterbalanced.
|
TMS is administered during the execution of sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
Other Names:
TMS is not administered during the execution of sequence-demanding task.
TMS is administered during the execution of non-sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
TMS is not administered during the execution of non-sequence-demanding task
|
|
Active Comparator: Occipital Stimulation
TMS will be administered to an occipital control region on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task.
Task order will be counterbalanced.
|
TMS is administered during the execution of sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
Other Names:
TMS is not administered during the execution of sequence-demanding task.
TMS is administered during the execution of non-sequence-demanding task.
Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
TMS is not administered during the execution of non-sequence-demanding task
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
functional magnetic resonance imaging brain activation
Time Frame: during scan up to 1 hour
|
functional magnetic resonance imaging brain activation.
For the sequential task, a sequence of letters is presented and the subject is presented with number signs, one at a time, to guide rehearsal of the sequence.
At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence.
For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented.
Brain activation in response to the probe will be measured with brain stimulation vs no brain stimulation for each task
|
during scan up to 1 hour
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
percent correct of behavioral responses
Time Frame: during scan up to 1 hour
|
percent correct of behavioral responses.
For the sequential task, a sequence of letters is presented and the subject is presented with # signs, one at a time, to guide rehearsal of the sequence.
At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence.
For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented.
Behavioral accuracy consists of the percent of correct responses to the probe, with higher numbers indicating better performance
|
during scan up to 1 hour
|
|
behavioral reaction time (milliseconds)
Time Frame: during scan up to 1 hour
|
behavioral reaction time to respond to the probe.
Increases in reaction time indicate greater difficulty for the subject to respond
|
during scan up to 1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: John E Desmond, Ph.D., Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB00328214
- R01MH128278 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.